FDA clears emergency use of drug to fight screwworm infections in pets
The U.S. Food and Drug Administration granted emergency use authorization for nitenpyram, a medication to treat New World screwworm infestations…
Wearables, and the data they generate, inch closer to entering the clinic
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech;…
‘Microbiological Contamination’: Dabur India Plant Gets Red Flag From US FDA Over Maintenance Lapses
At a time when Indian pharmaceutical and healthcare product manufacturers are facing increased scrutiny from US regulators over…
Industry and regulators signal a smarter, collaborative era for supplement oversight
While the industry has spent years bracing for and fending off a heavier regulatory hand, what it heard…
How GLP-1s are more than just weight-loss wonders – but not without risk
Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us did not even know what…
Controversial FDA official leaving drug center post in latest departure at agency
The leader of the Food and Drug Administration division responsible for regulating prescription and over-the-counter drugs is leaving…
‘Sugar Free’ & ‘No Sugar Added’ Aren’t The Same Thing—A Dietitian Explains The Difference
With increased scrutiny of ultra-processed foods, people are reading nutrition labels more closely than ever before. Brands are…
FDA Resubmission Path for Tab-cel Keeps Atara’s (ATRA) Regulatory Timeline Alive
medical research 7 ©Belova59 – pixabay.com Atara Biotherapeutics said the FDA outlined a potential pathway for resubmitting the…
Does FDA’s Rolling Review Of COMP360 Psilocybin Depression Therapy Change The Bull Case For COMPASS Pathways (CMPS)?
In April 2026, COMPASS Pathways announced that the FDA granted a rolling NDA review for its synthetic psilocybin…
Can Oral Ozempic and Label Expansions Revive NVO’s Near-Term Growth?
Novo Nordisk NVO is a dominant player in the GLP-1 space, marketing its semaglutide drugs under brand names Ozempic…
America’s debt problem is a health care problem
America has a spending problem. It also has a health care problem. These are not two separate crises…
20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs
Collection of sandflies, which can transmit river blindness Universal Images Group via Getty Images Occasionally I’ll go watch…